DOCSLIB.ORG

Copyrighted Material

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Index Note: Page numbers in italics refer to Figures; those in bold to Tables. activated clotting time (ACT), 35–9 interrupted aortic arch, 121 Blalock–Taussig shunt (BTS), 95, 114, Alfieri stitch, 172 luminal variation, 24, 25 115, 117, 129, 142, 149, 152, 155, alpha-stat blood gas management see placement, 79–80 159, 173, 177, 180 blood gas management regional perfusion strategies, 52–4, 115 blood coagulation see anticoagulation anomalous aortic origin of a coronary arterial decannulation, inadvertent, 73, management artery (AAOCA), 88 170 blood gas management anomalous left coronary artery from the arterial head occlusion, 29–30 alpha-stat management, 40–44 pulmonary artery (ALCAPA), 86 arterial line filters (ALF) on bypass, 80–81 anticoagulation management blood flow path, 13, 13 oxygenation strategy, 42–4 activated clotting time (ACT), 35–9 external, 12, 12, 13, 14, 61–2 pH-stat management, 40–44 blood coagulation pathways, 35, 35, 36 integral, 5–8, 9 blood pressure management coagulation factors, 35, 35 arterial pump failure (roller head), 164 cardiopulmonary bypass, 47–8 heparin concentration management, 37 arterial switch operation (ASO), 85, 112, cerebral blood flow (CBF), 47 prime volume 140, 141, 174–7 see also Jatene higher than expected, 148 circuit exposure, 36 procedure lower than expected, 149 examples, 14, 187, 188 arterio venous MUF (AVMUF), 56–9, 57 ranges, 48, 48 oxygenator primes, 5–8 atrial line, 77 blood prime see also priming procoagulant factors, 35, 36 placement, 82 blood volume, 31, 31 protamine dosing, 38–9 atrial septal defects (ASDs), 95–8, 97, 102, calcium and sodium bicarbonate, 31–2 surface-modifying agents (SMAs), 36 110, 121, 128, 129, 132, 133, 138, dilutional hematocrit, 30 aortic dissection, acute, 73, 168 140, 142, 176 hematocrit of blood product, 31 aortic insufficiency (AI), 74, 80, 89–90 augmented venous return prebypass filter, 30 aortic regurgitation (AR) see aortic kinetic-assisted venous drainage pump prime, 30–2 insufficiency (KAVD), 60–61 Brock procedure, 173 aortic stenosis (AS) roller pump-assisted venous drainage, 60 bypass plan critical, 107, 107–8 vacuum-assisted venous drainage anticoagulation management, 35–9 subvalvar/subaortic, 91 (VAVD), 61–2 augmented venous return, 60–62 supravalvar, 91, 92 blood gas management, 40–44 valvar, 91, 92 Batista procedure, 172 blood pressure management, 47–8 aortopulmonary collaterals (APCs), 41,COPYRIGHTED bed rotation, 83, 148, 149 MATERIALclosed-loop communication, 33 93–4, 94, 130, 136 Bentall procedure, 172 flow rates, 52 aortopulmonary window, 95, 95 bicaval cannulation, 20–23 hematocrit management, 45–6 arterial blood pressure management, 47, bidirectional Glenn (BDG) shunt, 114, hypothermic circulatory arrest, 52–4 48, 52, 148, 149, 168 116, 117, 172 methods of ultrafiltration, 55–9 arterial cannulae bilateral bidirectional Genn shunt prebypass checklist, 63, 63–4, 64 central aortic cannulation, 23–4, 24, 24 (BBDG), 117, 172 regional perfusion, 52–4 femoral cannulation, 25, 25 Blalock–Hanlon procedure, 172–3 standard venous return, 60 Perfusion for Congenital Heart Surgery: Notes on Cardiopulmonary Bypass for a Complex Patient Population, First Edition. Gregory S. Matte. © 2015 John Wiley & Sons, Inc. Published 2015 by John Wiley & Sons, Inc. 190 0002262967.indd 190 1/27/2015 5:29:40 PM Index 191 surgical safety checklist, 65–6 factors, 35, 35 d-transposition of the great arteries temperature management, 49–51 pathways, 35, 35 (d-TGA), 45, 112, 140–141, 141, phases, 35, 36 175, 176, 178 cannulae coarctation of the aorta (CoA), aortic arch anatomy, 20, 21 100–101, 101 Ebstein’s anomaly, 113, 113, 143, 173 arterial, 23–5, 24, 24, 25, 25, 79–80 colloidal primes, 27–8 emergency procedures cardiac anatomy, 20, 21 commencement of bypass acute aortic dissection, 168 central venous anatomy, 20, 21 arterial clamp removal, 73 arterial decannulation, pressure loss, 21–2, 23–4 cannulation, 72–3 inadvertent, 170 venous, 22, 22–3, 23 cooling, 74 arterial pump failure water charts, 22 full flow, 74 (roller head), 164 cannulation full scanning, 74 failure to oxygenate, 165 arterial cannula, 79–80 gas flow, 73 massive air embolus (MAE), 166–7 bicaval, 80 pump suckers, 72 venous air lock, 169 central aortic, 23–4, 24, 24 venous cannula, 73 venous decannulation, inadvertent, 171 femoral, 25, 25 complete atrioventricular canal (CAVC), endotracheal tube (ETT) for SVC pump lines, 79, 80 45, 102–3, 103 cannulation, 96, 96 transfusion, 80 cone procedure, 113, 173 equipment carbon dioxide flush, 29 congenitally corrected transposition of arterial line filters, 12–3 carbon dioxide management the great arteries (CCTGAs), 105, cannulae, 20–25 alpha-stat blood gas management, 40 105–6, 106 cardioplegia systems, 16–7 carbair/carbogen option, 43–4 continuous cardioplegia systems, 17 heart–lung machine (HLM), 17–9 crossover strategy, 42 conventional ultrafiltration (CUF), 55, heater-cooler system, 19–20 pH-stat blood gas management, 40–42 59, 75 oxygenators, 1–12 cardiac index, 52–4, 52 coronary sinus septal defect (CSSD), 96 selection chart, experience-based, 14, cardiomyopathy (CMO) Cor triatriatum, 104, 104 187, 188 Batista procedure, 172 Cox maze procedure, 173 tubing packs, 13–16 orthotopic heart transplantation, 99 cross-clamp time (CCT), 78 cardioplegia (CPG) systems crossover technique femoral cannulation, 23–5, 25 continuous, 17 for carbon dioxide management, 42 filtration systems, 9, 10 during standard support phase, 74–5 for oxygenation strategy, 43 flow rates equipment, 16–7 crystalloid during bypass, 52–4, 52 nonrecirculating, 17, 81, 89 heparin level, 30 oxygenator gas flow, 5–8 recirculating, 16, 16–7, 75, 81, 89 prebypass filter, 30 priming, 29–30 cardiopulmonary bypass time primes, 27–30, 28 water, 11, 19, 23–5, 23 (CPBT), 78 Fontan procedure, 110, 114, 119–20, cardiotomy filter, 2, 3, 9, 10–11 Damus–Kaye–Stansel anastomosis, 173 142, 174 cardiotomy venous reservoir (CVR), 2, deep hypothermic circulatory arrest 3, 9, 9 (DHCA), 50, 52–4, 165, gas flow rates, 40–42, 73, 90, 124, 155, caval tapes, 80 167, 168 157, 159–60 cavopulmonary anastomosis, 114, 116, defoaming agents, 9–11 Gott shunt, 174 117, 119, 172, 174, 180 dilutional ultrafiltration (DUF), 55–6, 59, Great Ormond Street Hospital MUF cell-based model of hemostasis, 102, 113, 125, 143 method (GOSH method), 35–6, 36 display systems, 19 56–8, 57 central aortic cannulation, 23–4, 24, 24 double-chambered right ventricle central shunt, 173 (DCRV), 109 heart–lung machine (HLM) central venous pressure (CVP), 73, 75, 77, double inlet left ventricle (DILV), components, 17–9 153, 161 110, 146 prebypass positioning, 79 cerebral perfusion pressure (CPP), 47 double-orifice technique see Alfieri heart transplantation, 99 cerebral vascular resistance, 47 stitch heater-cooler system circulatory arrest time (CAT), 52–4, 78 double outlet left ventricle (DOLV), 111 standalone heater-cooler unit, 19 closed bypass systems, 9 double outlet right ventricle (DORV), 85, Stockert heater-cooler system 3T, coagulation, see anticoagulation 112, 112, 178 20, 20 management double switch procedure, 105, 173–4 “wall water,” 20 0002262967.indd 191 1/27/2015 5:29:40 PM 192 Index heat exchange issue (slow cooling or levo transposition of the great arteries integrated ALF, 9 warming), 154 see congenitally corrected membrane heat exchanger transposition of the great blood flow paths, 4, 4 sizes, 5–8 arteries microporous, 1, 3, 4 performance factor, 11 lung transplantation, 124, 134 pressure drop, 4, 9 temperature gradients, 11 LV vent true, 1, 3 hematocrit management, 45–6 with aortic insufficiency, 89 Terumo CAPIOX FX series, 1, 2, 3, 9, 5–8 Hemi–Fontan procedure, 116, 117, 174 placement, 75, 83 oxygen toxicity, 42 hemofiltration, 55–9 heparin major aortopulmonary collateral arteries PaCO2 see blood gas management anticoagulation management, 35–9 (MAPCAs), 1, 10, 81, 93, 94, 95, Pannus, 176 antithrombin III level, 37 129, 130, 136, 138, 144 PaO2 see blood gas management crystalloid prime concentration, 30 Manougian procedure, 175 partial atrioventricular canal defect dosage, 37 Marfan’s syndrome, 175 (PAVC), 102 HDR curve, 37, 38 massive air embolus (MAE) patent ductus arteriosus, 74, 107, 121, 127, reversing anticoagulation effect, 38–9 operative measures, 166 127, 129, 130 heparin-dose response (HDR) curve, postoperative plan, 167 Pentalogy of Cantrell, 176 37–8, 38 vacuum-assisted venous drainage persistent left superior vena cava see left Holmes heart, 174 (VAVD), 61–2 superior vena cava hyperoxic technique, 43–4 maze procedure see Cox maze procedure phases of bypass hypoplastic left heart syndrome (HLHS), medications for bypass, 187, 189 bypass times, 78 114–20, 114 microplegia see continuous cardioplegia commencement, 72–4 bidirectional Glenn Shunt, 116, 117, systems post bypass, 78 172 mitral regurgitation/insufficiency (MR/ standard support phase, 74–6 Fontan procedure, 119, 119–20, 174 MI), 86, 125, 125, 172 termination, 76–7 hybrid stage 1 palliation, 117 mitral stenosis (MS), 126, 126, 178 pH-stat blood gas management see blood stage 2 or bidirectional Glenn shunt, modified BTS (mBTS) see Blalock– gas management 117–8, 116 Taussig shunt Potts shunt, 177 stage 1 procedure, 115, 115–7 modified ultrafiltration (MUF), 56–9, 56 prebypass hypothermic circulatory arrest (HCA), 43, GOSH MUF technique, 56, 57, 57–8 cannulation, 79–80 52–4 simplified (SMUF), 56–9 checklist, 63, 63–4, 64 Mustard procedure, 176 heart–lung machine (HLM), 79 induced fibrillation time (IFT), 78 reoperations, 79 induced ventricular fibrillation,
Recommended publications
  • Congenital Heart Disease

    Congenital Heart Disease

    GUEST EDITORIAL Congenital heart disease Pediatric Anesthesia is the only anesthesia journal ded- who developed hypoglycemia were infants. (9). Steven icated exclusively to perioperative issues in children and Nicolson take the opposite approach of ‘first do undergoing procedures under anesthesia and sedation. no harm’ (10). If we do not want ‘tight glycemic con- It is a privilege to be the guest editor of this special trol’ because of concern about hypoglycemic brain issue dedicated to the care of children with heart dis- injury, when should we start treating blood sugars? ease. The target audience is anesthetists who care for There are no clear answers based on neurological out- children with heart disease both during cardiac and comes in children. non-cardiac procedures. The latter takes on increasing Williams and Cohen (11) discuss the care of low importance as children with heart disease undergoing birth weight (LBW) infants and their outcomes. Pre- non-cardiac procedures appear to be at a higher risk maturity and LBW are independent risk factors for for cardiac arrest under anesthesia than those without adverse outcomes after cardiac surgery. Do the anes- heart disease (1). We hope the articles in this special thetics we use add to this insult? If prolonged exposure issue will provide guidelines for management and to volatile anesthetics is bad for the developing neona- spark discussions leading to the production of new tal brain, would avoiding them make for improved guidelines. outcomes? Wise-Faberowski and Loepke (12) review Over a decade ago Austin et al. (2) demonstrated the current research in search of a clear answer and the benefits of neurological monitoring during heart conclude that there isn’t one.
  • Pediatric Radiology

    Pediatric Radiology

    2013 RSNA (Filtered Schedule) Sunday, December 01, 2013 10:30-12:00 PM • VSPD11 • Room: S100AB • Pediatric Radiology Series: Pediatric Neuroimaging I 10:45-12:15 PM • SPOI11 • Room: E353C • Oncodiagnosis Panel: Pediatric Sarcoma (An Interactive Session) 12:30-01:00 PM • CL-PDS-SUA • Room: S101AB • Pediatric Radiology - Sunday Posters and Exhibits (12:30pm - 1:00pm) 01:00-01:30 PM • CL-PDS-SUB • Room: S101AB • Pediatric Radiology - Sunday Posters and Exhibits (1:00pm - 1:30pm) 02:00-03:30 PM • VSPD12 • Room: S102AB • Pediatric Radiology Series: Pediatric Musculoskeletal Monday, December 02, 2013 08:30-10:00 AM • RC224 • Room: E353B • Mentored Case Approach to Pediatric Cardiovascular Disease 1: Vascular Disease (An Interactive Session) 08:30-12:00 PM • VSPD21 • Room: S102AB • Pediatric Radiology Series: Fetal - Neonatal Imaging 12:15-12:45 PM • CL-PDS-MOA • Room: S101AB • Pediatric Radiology - Monday Posters and Exhibits (12:15pm - 12:45pm) 12:45-01:15 PM • CL-PDS-MOB • Room: S101AB • Pediatric Radiology - Monday Posters and Exhibits (12:45pm - 1:15pm) 03:00-04:00 PM • SSE21 • Room: S102AB • Pediatric (Neuroimaging) Tuesday, December 03, 2013 08:30-10:00 AM • RC324 • Room: S402AB • Mentored Case Approach to Pediatric Cardiovascular Disease 2: Cardiac Disease (An Interactive Session) 08:30-12:00 PM • VSPD31 • Room: S102AB • Pediatric Radiology Series: Chest/Cardiovascular Imaging I 12:15-12:45 PM • CL-PDS-TUA • Room: S101AB • Pediatric Radiology - Tuesday Scientific Posters and Exhibits (12:15pm - 12:45pm) 12:45-01:15 PM • CL-PDS-TUB •
  • Bentall Procedure: Quarter Century of Clinical Experiences of a Single

    Bentall Procedure: Quarter Century of Clinical Experiences of a Single

    Benke et al. Journal of Cardiothoracic Surgery (2016) 11:19 DOI 10.1186/s13019-016-0418-y RESEARCHARTICLE Open Access Bentall procedure: quarter century of clinical experiences of a single surgeon Kálmán Benke1,3*, Bence Ágg1,3, Lilla Szabó1, Bálint Szilveszter1,4, Balázs Odler2, Miklós Pólos1, Chun Cao1, Pál Maurovich-Horvat1,4, Tamás Radovits1, Béla Merkely1 and Zoltán Szabolcs1,3 Abstract Background: We retrospectively analyzed 25 years of experiences with the button Bentall procedure in patients with aortic root pathologies. Even though this procedure has become widespread, there are only a few very long term follow-ups available in the clinical literature, especially regarding single surgeon results. Methods: Between 1988 and 2013, a total of 147 patients underwent the Bentall procedure by the same surgeon. Among them there were 62 patients with Marfan syndrome. At the time of the surgery the mean age was 46.5 ± 17.6 years. The impact of surgical experience on long-term survival was evaluated using a cumulative sum analysis chart. Results: The Kaplan-Meier estimated overall survival rates for the 147 patients were 91.8 ± 2.3 %, 84.3 ± 3.1 %, 76.3 ± 4.9 % and 59.5 ± 10.7 % at 1,5,10 and 20 years, respectively. Multivariate Cox regression analysis identified EuroSCORE II over 3 % (OR 4.245, 95 % CI, 1.739–10.364, p = 0.002), acute indication (OR 2.942, 95 % CI, 1.158–7.480, p = 0.023), use of deep hypothermic circulatory arrest (OR 3.267, 95 % CI, 1.283–8.323, p = 0.013), chronic kidney disease (OR 6.865, 95 % CI, 1.339–35.189, p = 0.021) and early complication (OR 3.134, 95 % CI, 1.246–7.883, p = 0.015) as significant risk factors for the late overall death.
  • Overview of Partial Left Ventriculectomy

    Overview of Partial Left Ventriculectomy

    Prepared by ASERNIP-S NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of Partial Left Ventriculectomy Introduction This overview has been prepared to assist members of IPAC advise on the safety and efficacy of an interventional procedure previously reviewed by SERNIP. It is based on a rapid survey of published literature, review of the procedure by specialist advisors and review of the content of the SERNIP file. It should not be regarded as a definitive assessment of the procedure. Procedure name Partial Left Ventriculectomy The Batista Procedure Specialty society Society of Cardiothoracic Surgeons of Great Britain and Ireland Executive Summary Left partial ventriculectomy (PLV) seeks to treat dilated cardiomyopathy by reducing cardiac volume and hence heart wall pressure through the resection of a portion of the left ventricle. Patients receiving it are generally suitable for cardiac transplant but unable to receive it, often for social or economic reasons. PLV is an emerging procedure and the vast majority of evidence is case series, although there has been one retrospective comparative study of PLV and transplantation. Hospital mortality was reported for up to 30% of patients and overall mortality was around 40% of patients. Thirty day survival ranged from 50% to 99%, and no significant difference was found between PLV and transplant. One-year survival ranged from 46% to 80% and three- year survival was reported in one study as 60%. Event-free survival was reported as 80% at 30 days, 49% at 1 year and 26% at three years. Use of a left ventricular assist device or relisting for cardiac surgery was reported in one study at between 5% and 15% of patients at 30 days and in 43% at 1 year and 58% at 3 years.
  • Thursday Poster Assignment

    Thursday Poster Assignment

    Corresponding Author Paper Title Board Assignment Number ‐ Thursday Classification of Typical Developing and Autism Spectrum Disorder Using Connectivity A.R., Jac Fredo Matrix and Support Vector Machine 111 Abbaszadeh, Behrooz Probabilistic Prediction of Epileptic Seizures Using SVM 220 Abe, Takuto Surrogate Modeling for Neuroprotective Focal Brain Cooling Device 110 Comprehensive Comparison of 2D vs. 3D Resource Usage in Large Volumetric Medical Agris, Jacob Image Segmentation 109 On Smartphone Sensability of Bi‐Phasic User Intoxication Levels from Diverse Walk Agu, Emmanuel Types in Standardized Field Sobriety Tests 327 The Effect of Perceived Sound Quality of Speech in Noisy Speech Perception by Akbarzadeh, Sara Normal Hearing and Hearing Impaired Listeners 370 Towards the Development of an Optrode Biopotential Sensor: Characterization Using Al Abed, Amr in Vitro Cardiac Tissue Recordings 108 Spatially Filtered Low‐Density EMG and Time‐Domain Descriptors Improves Hand Al‐Jumaily, Adel Movement Recognition 419 Optimizing Stimulation Strategies for Retinal Electrical Stimulation: A Modelling Study Alqahtani, Abdulrahman 287 An Automatic Navigation and Pressure Monitoring for Guided Insertion Procedure Alsunaydih, Fahad Nasser 326 A Statistical Determination of the Energy Delivered to Muscular Tissue in Amador, Alejandro Electrostimulation Protocols 149 Analysis of Muscle Fatigue During Exercise and Exercise Combined with Electrostimulation 151 Signal‐To‐Noise Ratio Determination in a Hybrid System of Electrostimulation and Electromiography 150 Continuous Prediction of Cognitive State Using a Marked‐Point Process Modeling Amidi, Yalda Framework 286 Antônio Freire Teixeira, Marcos Automatic Counting of Erythrocytes Using Image Processing 153 Feature Extraction from Radiographic Images for Bone Age Identification 152 Arantes, Ana Paula Bittar Britto Towards the Improvement of Algorithms Used in Robot‐Assisted Therapies 107 Arce‐Diego, José L.
  • Reduction Ventriculoplasty for Dilated Cardiomyopathy : the Batista Procedure Shahram Salemy Yale University

    Reduction Ventriculoplasty for Dilated Cardiomyopathy : the Batista Procedure Shahram Salemy Yale University

    Yale University EliScholar – A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 1999 Reduction ventriculoplasty for dilated cardiomyopathy : the Batista procedure Shahram Salemy Yale University Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl Recommended Citation Salemy, Shahram, "Reduction ventriculoplasty for dilated cardiomyopathy : the Batista procedure" (1999). Yale Medicine Thesis Digital Library. 3123. http://elischolar.library.yale.edu/ymtdl/3123 This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital Platform for Scholarly Publishing at Yale. For more information, please contact [email protected]. SlDDCITOM VENTRICULOPIASTy FOR DILATED CARDIOMYOPATHY THE BATISTA PROCEDURE W«M * (e,yx»> ShaLramSalemy YALE DNIVERSriY YALE UNIVERSITY CUSHING/WHITNEY MEDICAL LIBRARY Permission to photocopy or microfilm processing of this thesis for the purpose of individual scholarly consultation or reference is hereby granted by the author. This permission is not to be interpreted as affecting publication of this work or otherwise placing it in the public domain, and the author reserves all rights of ownership guaranteed under common law protection of unpublished manuscripts. Signature of Author Date REDUCTION VENTRICULOPLASTY FOR DILATED CARDIOMYOPATHY: THE BATISTA PROCEDURE Shahram Salemy B.S., George Tellides M.D., Ph.D., and John A. Elefteriades M.D. February 5, 1999 r 113 f'Uh (e(e.cl 0 REDUCTION VENTRICULOPLASTY FOR DILATED CARDIOMYOPATHY: THE BATISTA PROCEDURE.
  • Selected Terms Used in Adult Congenital Heart Disease Jack M

    Selected Terms Used in Adult Congenital Heart Disease Jack M

    SELECTED TERMS USED IN ADULT CONGENITAL HEART DISEASE JACK M. COLMAN | ERWIN NOTKER OECHSLIN | MATTHIAS GREUTMANN | DANIEL TOBLER ambiguus A With reference to cardiac situs, neither right nor left sided aberrant innominate artery (indeterminate). Latin spelling is generally used for situs ambig- A rare abnormality associated with right aortic arch compris- uus. Syn: ambiguous sidedness. See also situs. ing a sequence of arteries arising from the aortic arch—right carotid artery, right subclavian artery, and then (left) innomi- Amplatzer device nate artery—with the last passing behind the esophagus. This A group of self-centering devices delivered percutaneously by is in contrast to the general rule that the first arch artery gives catheter for closure of abnormal intracardiac and vascular con- rise to the carotid artery contralateral to the side of the aortic nections such as secundum atrial septal defect, patent foramen arch (ie, right carotid artery in left aortic arch and left carotid ovale or patent ductus arteriosus. artery in right aortic arch). Syn: retroesophageal innominate artery. Anderson-Fabry disease See Fabry disease aberrant subclavian artery Right subclavian artery arising from the aorta distal to the left aneurysm of sinus of Valsalva subclavian artery. Left aortic arch with (retroesophageal) aber- See sinus of Valsalva/aneurysm. rant right subclavian artery is the most common aortic arch anomaly. It was first described in 1735 by Hunauld and occurs anomalous pulmonary venous connection in 0.5% of the general population. Syn: lusorian artery. See also Pulmonary venous connection to the right side of the heart, vascular ring. which may be total or partial.
  • An Overview of Mechanical Circulatory Support in Single-Ventricle Patients

    An Overview of Mechanical Circulatory Support in Single-Ventricle Patients

    161 Review Article An overview of mechanical circulatory support in single-ventricle patients Jacob R. Miller1, Timothy S. Lancaster1, Connor Callahan2, Aaron M. Abarbanell3, Pirooz Eghtesady3 1Division of Cardiothoracic Surgery, 2Department of Surgery, Barnes-Jewish Hospital/Washington University School of Medicine, St. Louis, MO, USA; 3Section of Pediatric Cardiothoracic Surgery, St. Louis Children’s Hospital/Washington University School of Medicine, St. Louis, MO, USA Contributions: (I) Conception and design: JR Miller, AM Abarbanell, P Eghtesady; (II) Administrative support: AM Abarbanell, P Eghtesady; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: JR Miller, TS Lancaster, C Callahan; (V) Data analysis and interpretation: JR Miller, AM Abarbanell, P Eghtesady; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Pirooz Eghtesady, MD, PhD. Chief of Pediatric Cardiothoracic Surgery, St. Louis Children’s Hospital, One Children’s Place, Suite 5 South, St. Louis, MO 63110, USA. Email: [email protected]. Abstract: The population of people with a single-ventricle is continually increasing due to improvements across the spectrum of medical care. Unfortunately, a proportion of these patients will develop heart failure. Often, for these patients, mechanical circulatory support (MCS) represents the only available treatment option. While single-ventricle patients currently represent a small proportion of the total number of patients who receive MCS, as the single-ventricle patient population increases, this number will increase as well. Outcomes for these complex single-ventricle patients who require MCS has begun to be evaluated. When considering the entire population, survival to hospital discharge is 30–50%, though this must be considered with the significant heterogeneity of the single-ventricle patient population.
  • Outcome of the Norwood Operation in Patients with Hypoplastic Left Heart Syndrome: a 12-Year Single-Center Survey

    Outcome of the Norwood Operation in Patients with Hypoplastic Left Heart Syndrome: a 12-Year Single-Center Survey

    Furck et al Congenital Heart Disease Outcome of the Norwood operation in patients with hypoplastic left heart syndrome: A 12-year single-center survey Anke Katharina Furck, MD,a Anselm Uebing, MD,a Jan Hinnerk Hansen,a Jens Scheewe, MD,b Olaf Jung, MD,a Gunther Fischer, MD,a Carsten Rickers, MD,a Tim Holland-Letz, MSc,c and Hans-Heiner Kramer, MDa Objective: Recent advances in perioperative care have led to a decrease in mortality of children with hypoplastic left heart syndrome undergoing the Norwood operation. This study aimed to evaluate the outcome of the Nor- wood operation in a single center over 12 years and to identify clinical and anatomic risk factors for adverse early CHD and longer term outcome. Methods: Full data on all 157 patients treated between 1996 and 2007 were analyzed. Results: Thirty-day mortality of the Norwood operation decreased from 21% in the first 3 years to 2.5% in the last 3 years. The estimated exponentially weighted moving average of early mortality after 157 Norwood oper- ations was 2.3%. Risk factors were an aberrant right subclavian artery, the use and duration of circulatory arrest, and the duration of total support time. The anatomic subgroup mitral stenosis/aortic atresia and female gender tended to show an increased early mortality. In the group of patients who required postoperative cardiopulmonary resuscitation, the ascending aorta was significantly smaller than in the remainder (3.03 Æ 1.05 vs 3.63 Æ 1.41 mm). Interstage mortality was 15% until the initiation of a home surveillance program in 2005, which has zeroed it so far.
  • Coders' Desk Reference for ICD-10-PCS Procedures

    Coders' Desk Reference for ICD-10-PCS Procedures

    2 0 2 DESK REFERENCE 1 ICD-10-PCS Procedures ICD-10-PCS for DeskCoders’ Reference Coders’ Desk Reference for ICD-10-PCS Procedures Clinical descriptions with answers to your toughest ICD-10-PCS coding questions Sample 2021 optum360coding.com Contents Illustrations ..................................................................................................................................... xi Introduction .....................................................................................................................................1 ICD-10-PCS Overview ...........................................................................................................................................................1 How to Use Coders’ Desk Reference for ICD-10-PCS Procedures ...................................................................................2 Format ......................................................................................................................................................................................3 ICD-10-PCS Official Guidelines for Coding and Reporting 2020 .........................................................7 Conventions ...........................................................................................................................................................................7 Medical and Surgical Section Guidelines (section 0) ....................................................................................................8 Obstetric Section Guidelines (section
  • TAKING HEART from 20 YEARS of PROGRESS P10 Dear Colleagues

    TAKING HEART from 20 YEARS of PROGRESS P10 Dear Colleagues

    INSIDE THIS ISSUE Introducing the Wound Care for Tetralogy of Cardiovascular ‘No Option’ Fallot in Adults Specialty Network Patients – p14 – p17 – p3 Cardiac Consult Heart and Vascular News from Cleveland Clinic | Fall 2014 | Vol. XXIV No. 3 TAKING HEART FROM 20 YEARS OF PROGRESS p10 Dear Colleagues: Cardiac Consult is a forward-thinking publication. But in this issue’s cover story (p. 10), we look back over the past 20 years of cardiovascular achievement. The piece is both a fun way to take stock of how our discipline has evolved and a not-so-subtle reminder that for every one of those 20 years, Cleveland Clinic has been ranked No. 1 for heart care in U.S. News & World Report’s “Best Hospitals” survey. If you wonder how Cleveland Clinic is able to consistently earn this standing year after year, the remaining articles in this issue might give some clues. The feature on p. 3 profiles our new Cardiovascular Specialty Network and other heart care-focused affiliations and alliances with hospitals and Cardiac Consult offers updates on advanced providers nationwide. The network and affiliations are made possible by diagnostic and management techniques Cleveland Clinic’s standardized approach to patient care. Our cardiovascu- from specialists in Cleveland Clinic’s Sydell and Arnold Miller Family Heart & Vascular lar specialists strive for predictable outcomes through close observation of Institute. Please direct correspondence to: data, evidence-based practices and continuous quality improvement. These Medical Editors specialists’ services are coordinated elements of a single Heart & Vascular Amar Krishnaswamy, MD Institute comprising cardiovascular and thoracic surgery, vascular surgery, [email protected] and cardiovascular medicine.
  • THÈSE DE DOCTORAT DE « Clémentine SHAO »

    THÈSE DE DOCTORAT DE « Clémentine SHAO »

    THÈSE DE DOCTORAT DE L’UNIVERSITE DE RENNES 1 COMUE UNIVERSITE BRETAGNE LOIRE Ecole Doctorale N°601 Mathématique et Sciences et Technologies de l’Information et de la Communication Spécialité : Signal, Image, Vision Par « Clémentine SHAO » « Images and models for decision support in aortic dissection surgery » «Images et modèles pour l’aide à la décision clinique de la chirurgie de la dissection aortique» Thèse présentée et soutenue à RENNES , le 16/12/19 Unité de recherche : LTSI, Inserm U1099 Thèse N° : Rapporteurs avant soutenance : Frans Van De Vosse, PR, Eindhoven University of Technology (TU/e), Netherlands Alain Lalande, MCU-PH, Université de Bourgogne Franche-Comté, France Composition du jury : Président : Examinateurs : Alain Lalande, MCU-PH, Université de Bourgogne Franche-Comté, France Nadjia Kachenoura, CR INSERM, Sorbonne Universités, France Frans Van De Vosse, PR, Eindhoven University of Technology (TU/e), Netherlands Jean-Philippe Verhoye, PU-PH, CHU de Rennes, France Dir. de thèse : Pascal Haigron, PR, Université de Rennes 1, France Co-dir. de thèse : Gabriele Dubini, PR, Politecnico di Milano, Italie Invité(s) Michel Rochette, Directeur Technique, Ansys France, France ACKNOWLEDGEMENT Je tiens à remercier I would like to thank. my parents.. J’adresse également toute ma reconnaissance à .... .... i LIST OF ABBREVIATIONS AA Ascending Aorta AD Aortic Dissection BC Boundary Condition BT Brachiocephalic Trunk CFD Computational Fluid Dynamics CT Computed Tomography CVS Cardiovascular System DA Descending Aorta DOE Design Of Experiment